NCT00032786View on ClinicalTrials.gov

Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

March 31, 2002

Primary Completion Date

March 31, 2004

Study Completion Date

March 31, 2004

Conditions

Crohn's Disease

Interventions

DRUG

natalizumab

Sponsors

Lead Sponsor

Collaborators (1)

Elan Pharmaceuticals

All Listed Sponsors

collaborator

Elan Pharmaceuticals

INDUSTRY

lead

Biogen

INDUSTRY